Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇨🇦CA · Investing#1535K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2.5K to 15K🎙 ~2x weekly·33 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
5K to 30K🇨🇦100% - Active Followers
Loyal subscribers who consistently listen
2K to 12K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHost
Recent guests
Recent episodes
SpaceX IPO: Inside Elon Musk's $1.75 Trillion Bet On Rockets, Satellites And AI
Mar 30, 2026
22m 28s
How This Uranium Enrichment Technology Aims To Solve The Nuclear Fuel Bottleneck For Big Tech
Mar 9, 2026
25m 43s
Rare Earth Race: Why The U.S. Is Paying Billions To Break China’s Mineral Monopoly
Mar 6, 2026
23m 28s
Why The Next Big AI Concern Runs Through Main Street
Dec 30, 2025
28m 17s
Novo Nordisk Is Losing Its Lead To Eli Lilly In The Obesity Drug War. Here’s What Went Wrong.
Aug 15, 2025
19m 19s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 3/30/26 |  SpaceX IPO: Inside Elon Musk's $1.75 Trillion Bet On Rockets, Satellites And AI✨ | SpaceX IPOElon Musk+4 | SpaceX investors | SpaceXInvestor's Business Daily | — | SpaceXIPO+5 | — | 22m 28s | |
| 3/9/26 |  How This Uranium Enrichment Technology Aims To Solve The Nuclear Fuel Bottleneck For Big Tech✨ | nuclear energyuranium enrichment+3 | Jay Yu | LIS TechnologiesInvestor's Business Daily | — | nuclear fuelenergy future+4 | — | 25m 43s | |
| 3/6/26 |  Rare Earth Race: Why The U.S. Is Paying Billions To Break China’s Mineral Monopoly✨ | rare earth industrygeopolitics+3 | Reed Blakemore | Atlantic CouncilInvestor's Business Daily | U.S.China | rare earthChina+5 | — | 23m 28s | |
| 12/30/25 |  Why The Next Big AI Concern Runs Through Main Street✨ | AI concernsdata centers+4 | — | IBDBig Tech | — | AIdata centers+5 | — | 28m 17s | |
| 8/15/25 |  Novo Nordisk Is Losing Its Lead To Eli Lilly In The Obesity Drug War. Here’s What Went Wrong.✨ | obesity drugspharmaceutical rivalry+3 | — | Novo NordiskEli Lilly | Denmark | Novo NordiskEli Lilly+3 | — | 19m 19s | |
| 7/28/25 |  Nano Nuclear Energy Has Surged 650% Since Its Public Debut. CEO Says Growth Is Just Getting Started.✨ | nuclear energyportable power+3 | James Walker | Nano Nuclear EnergyInvestor's Business Daily | — | Nano Nuclear Energynuclear power+3 | — | 20m 12s | |
| 7/22/25 |  Netflix's Trillion-Dollar Quest: Inside The Streamer's Bold Bet On Future Growth✨ | Netflixtrillion-dollar companies+3 | — | NetflixWall Street+1 | — | Netflixtrillion-dollar quest+3 | — | 16m 42s | |
| 6/13/25 |  Trump's China Deal Catapults Rare Earths Into Global Focus✨ | trade agreementrare earths+3 | — | rare earthsChina+1 | — | trade agreementChina+3 | — | 13m 27s | |
| 5/16/25 |  Biotech's Next Boom? Inside The Multibillion Dollar Cancer Detection Market✨ | biotechcancer detection+3 | — | cancer detection testsInvestor's Business Daily | — | biotechcancer detection+3 | — | 13m 35s | |
| 5/5/25 |  AI Cyber Arms Race: What Trends Will Define The $135 Billion Fight For Market Dominance?✨ | AIcybersecurity+4 | Wendi Whitmore | Palo Alto Networks | — | AI revolutioncybersecurity+4 | — | 18m 44s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/21/25 |  Nvidia Executive Details Robotics Vision: 'We're A Market Maker' | On this episode of Growth Stories, we're joined by Nvidia's vice president of omniverse and simulation technology Rev Lebaredian, to hear how the AI titan plans to ignite a new growth chapter by bringing AI into the physical world. Learn more about your ad choices. Visit megaphone.fm/adchoices | 30m 01s | ||||||
| 3/6/25 |  Palantir Is Shaking Up The Defense Sector. What Comes Next As The AI Revolution Heads To The Front Lines? | On this episode of Growth Stories, we take a look at Palantir CEO Alex Karp's plans to redefine the military industrial complex and how defense companies are maneuvering to stay competitive in the age of artificial intelligence. Learn more about your ad choices. Visit megaphone.fm/adchoices | 19m 24s | ||||||
| 1/7/25 |  Nvidia Has Dominated The AI Revolution. Can The Chipmaker Stay At The Front Of The Pack? | While demand for AI chips has driven Nvidia stock's astronomical climb over the last few years, earnings growth has been decelerating and more rivals are looking to gain market share by producing their own high-powered chips. That has left investors to wonder if Nvidia can keep the party going as the competition heats up. On this episode of Growth Stories, we dive into Nvidia's 2025 outlook and how CEO Jensen Huang plans to keep the chipmaker front and center of the AI revolution. Learn more about your ad choices. Visit megaphone.fm/adchoices | 15m 31s | ||||||
| 11/8/24 |  How This Cybersecurity Leader Plans To Combat The Growing Threat Of AI Computer Attacks | On this Growth Stories Spotlight, we talk to Sam Rubin, VP & global head operations of Unit 42 at Palo Alto Networks, to discuss AI's role in cybersecurity and key themes for the industry in the year ahead. Learn more about your ad choices. Visit megaphone.fm/adchoices | 12m 27s | ||||||
| 10/24/24 |  The Chip War With China Is Heating Up. Who’s Winning? | America has led the world in designing and building the most advanced chips in the market. But that position is being challenged as big manufacturing hubs like Taiwan and Korea rise in prominence. And massive government spending efforts in China to bolster its chip industry also threaten to upend the U.S.’s competitive advantage in the sector. Policymakers have responded with subsidies to boost domestic chipmakers and bring some components of production back to U.S. soil. But industry leaders say it will be a long road. On this Growth Stories Spotlight, we speak to Chris Miller, economic historian and author of the book “Chip War: The Fight for the World’s Most Critical Technology,” to get his thoughts on the state of the industry and the race to reassert America’s dominance over the global semiconductor sector. Learn more about your ad choices. Visit megaphone.fm/adchoices | 16m 18s | ||||||
| 8/8/24 |  The Cell Therapy Market Is Expected To Grow 600% Over The Next Decade. This Biotech Is Poised To Capitalize On That Wave. | Over the last decade, cell therapies have attracted a lot of investor attention to biotechs. These groundbreaking treatments use a patient's own cells to create personalized medicine that not only improves wellness outcomes for people, but it has the ability to transform the health care and pharmaceutical industries. On this Growth Stories Spotlight, we talk to Vericel CEO Nick Colangelo to get his insights on the cell therapy market, his plans to expand MACI and burn care treatments and why he thinks Vericel has a unique position in the competitive landscape. Learn more about your ad choices. Visit megaphone.fm/adchoices | 20m 00s | ||||||
| 7/16/24 |  Tesla's Robotaxi Is Delayed. Will It Make A Difference For Tesla Stock? | Tesla is looking for its next big win. And the company is focusing on self-driving cars as a key part of its long-term strategy. On this Growth Stories Spotlight, we take a look at Tesla's upcoming robotaxi event and why the company is centering its future around a technology it's had trouble executing — and how the investing community might react. Learn more about your ad choices. Visit megaphone.fm/adchoices | 12m 07s | ||||||
| 6/17/24 |  If Tesla Is The Most Valuable Car Company, Why Are Hybrids Outselling EVs? | What market saw record sales growth last year and is considered a disappointment? That would be electric vehicles. Back in 2021, automakers went all in on battery-powered cars, committing billions of dollars to EV production. But just a few years later, that future is looking a bit hazy as a host of factors have seemingly put the brakes on the EV transition. And consumers who aren't ready to go all in on battery power are turning more and more to hybrid models. On this episode of Growth Stories, we take a look at the evolving electric vehicle market and what those changes signify for automakers—and investors—as they navigate the EV transition. Learn more about your ad choices. Visit megaphone.fm/adchoices | 21m 44s | ||||||
| 5/13/24 |  Celsius CEO Says These Three Megatrends Will Fuel Energy Drink Growth | Since its market debut in 2017, Celsius has been 'bubbling' up explosive growth for investors. But the company's turbocharged performance has set a high bar — leaving investors and Wall Street to wonder if Celsius' fast pace of growth is sustainable. On this Growth Stories Spotlight, Celsius CEO John Fieldly talks about the energy drink market and the growth drivers pushing Celsius forward in the year ahead. Learn more about your ad choices. Visit megaphone.fm/adchoices | 13m 41s | ||||||
| 4/24/24 |  This Cloud Stock Has Surged 100% In The Last Year. Will AI Innovations Keep The Momentum Going? | On this Growth Stories Spotlight, Informatica CEO Amit Walia gives us details on how the AI megatrend is boosting cloud computing growth and why being the Switzerland of data is helping the company stand out in the competitive data management landscape. Learn more about your ad choices. Visit megaphone.fm/adchoices | 17m 39s | ||||||
| 4/17/24 |  Spotlight: Arm Stock Eyes This Segment As Software Will Become ‘Survival’ For Automakers | Since its blockbuster return to the public market in September 2023, chip designer Arm has dazzled investors with its strong price history. And while the company is known for its mobile phone technology, CEO Rene Haas has signaled that Arm’s automotive segment is a key area of focus as the era of smart cars has upped the demand — and price — for the high-performing chips powering our vehicles. On this Growth Stories Spotlight, Arm’s head of automotive Dipti Vachani takes us on a deep dive into the chip designer’s strategy and why the company is focused on the auto segment as a pillar of future success. Learn more about your ad choices. Visit megaphone.fm/adchoices | 26m 02s | ||||||
| 4/8/24 |  Tesla Is Struggling. Here's What Elon Musk Is Betting On For Future Growth. | It's been a bumpy ride for Tesla stock over the last year as the EV automaker deals with increased competition and softening demand. As Elon Musk tries to navigate the company through choppy growth waves, will investors' patience with Tesla chart the same course? IBD news editor Ed Carson breaks down the bull and bear cases for Tesla stock. Learn more about your ad choices. Visit megaphone.fm/adchoices | 13m 11s | ||||||
| 3/27/24 |  Spotlight: Adobe Outperformed Microsoft In 2023. Can It Do It Again? | Adobe was one of the hottest stocks in 2023 thanks to the artificial intelligence tidal wave. But that growth has slowed as the AI feeding frenzy begins to settle. Adobe saw a similar pullback last year before the introduction of Firefly propelled shares higher. And with new AI powered-tools taking center stage at this year’s Adobe Summit, investors will find out if Adobe stock will sing a similar tune — or fall out of rhythm with the market. On this Growth Stories Spotlight, we speak to Anil Chakravarthy, who heads the digital experience business at Adobe, to get an inside look at the company’s AI strategy and the road ahead. Learn more about your ad choices. Visit megaphone.fm/adchoices | 15m 27s | ||||||
| 12/11/23 | CRSP Stock Is On A Wild Ride After Sickle Cell Treatment Approval. These Diseases Could Be Next. | Biotech stocks could be at a major turning point after FDA approval of the first gene editing drug using CRISPR technology to treat sickle cell disease. Government approval of these groundbreaking treatments could generate an unprecedented wave of medical innovation. But gene editing therapies aren't without risk, and questions remain about the safety and cost effectiveness of these experimental treatments. On this episode of Growth Stories, we dive into the science of gene editing treatments and how the boom in gene therapy drug approvals could transform the healthcare industry. Learn more about your ad choices. Visit megaphone.fm/adchoices | 18m 46s | ||||||
| 10/23/23 |  Microsoft Is Making A Big Bet As The Entire Tech Industry Goes All In On AI. Will It Win Or Lose? | Microsoft became a dominant tech powerhouse when Windows PCs and Internet Explorer emerged as critical tools of the web revolution. Now the software giant is trying to regain its leadership role with generative artificial intelligence — and Wall Street is paying close attention. On this episode of Growth Stories, we look at Microsoft’s push into artificial intelligence — and how the tech titan plans to use that technology to fuel a new era of growth. Learn more about your ad choices. Visit megaphone.fm/adchoices | 16m 57s | ||||||
Showing 25 of 33
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.